Copper Histidine
Unknown
Overview
Copper Histidine is a unknown active pharmaceutical ingredient (ChEMBL CHEMBL4297731).
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Copper Histidine expires — and exclusivity 12 Jan 2033. Generic API sourcing typically opens up once these lapse.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.